Furthermore, the expression of LunX mRNA in peripheral blood was sensitive to be influenced by the treatment of NSCLC patients (Figure 5), indicating that LunX mRNA expression might be associated with lung cancer progression. Here, BPIFA1 is linked to lung cancer.